317 related articles for article (PubMed ID: 31482205)
1. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody.
Marcinkowska M; Stanczyk M; Janaszewska A; Gajek A; Ksiezak M; Dzialak P; Klajnert-Maculewicz B
Polymers (Basel); 2019 Aug; 11(9):. PubMed ID: 31470686
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
[TBL] [Abstract][Full Text] [Related]
4. Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody-Trastuzumab: The New Approach of a Well-Known Strategy.
Marcinkowska M; Sobierajska E; Stanczyk M; Janaszewska A; Chworos A; Klajnert-Maculewicz B
Polymers (Basel); 2018 Feb; 10(2):. PubMed ID: 30966223
[TBL] [Abstract][Full Text] [Related]
5. Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization,
Raikwar S; Yadav V; Jain S; Jain SK
J Liposome Res; 2024 Jun; 34(2):239-263. PubMed ID: 37594466
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer.
Kulhari H; Pooja D; Shrivastava S; Kuncha M; Naidu VGM; Bansal V; Sistla R; Adams DJ
Sci Rep; 2016 Apr; 6():23179. PubMed ID: 27052896
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab Targeted Neratinib Loaded Poly-Amidoamine Dendrimer Nanocapsules for Breast Cancer Therapy.
Aleanizy FS; Alqahtani FY; Seto S; Al Khalil N; Aleshaiwi L; Alghamdi M; Alquadeib B; Alkahtani H; Aldarwesh A; Alqahtani QH; Abdelhady HG; Alsarra I
Int J Nanomedicine; 2020; 15():5433-5443. PubMed ID: 32801698
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Kumar Mehata A; Bharti S; Singh P; Viswanadh MK; Kumari L; Agrawal P; Singh S; Koch B; Muthu MS
Colloids Surf B Biointerfaces; 2019 Jan; 173():366-377. PubMed ID: 30316083
[TBL] [Abstract][Full Text] [Related]
9. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Bhatt H; Ghosh B; Biswas S
Int J Pharm; 2019 Feb; 557():329-341. PubMed ID: 30599231
[TBL] [Abstract][Full Text] [Related]
10. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab targeted micellar delivery of docetaxel using dendron-polymer conjugates.
Sumer Bolu B; Golba B; Sanyal A; Sanyal R
Biomater Sci; 2020 May; 8(9):2600-2610. PubMed ID: 32239010
[TBL] [Abstract][Full Text] [Related]
12. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity.
Houdaihed L; Evans JC; Allen C
Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330
[TBL] [Abstract][Full Text] [Related]
13. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Ghosh B; Biswas S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
[TBL] [Abstract][Full Text] [Related]
14. Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells.
Miyano T; Wijagkanalan W; Kawakami S; Yamashita F; Hashida M
Mol Pharm; 2010 Aug; 7(4):1318-27. PubMed ID: 20527783
[TBL] [Abstract][Full Text] [Related]
15. An analytical study of Trastuzumab-dendrimer-fluorine drug delivery system in breast cancer therapy in vitro.
Bartusik-Aebisher D; Chrzanowski G; Bober Z; Aebisher D
Biomed Pharmacother; 2021 Jan; 133():111053. PubMed ID: 33378959
[TBL] [Abstract][Full Text] [Related]
16. Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells.
Otis JB; Zong H; Kotylar A; Yin A; Bhattacharjee S; Wang H; Baker JR; Wang SH
Oncotarget; 2016 Jun; 7(24):36002-36013. PubMed ID: 27144519
[TBL] [Abstract][Full Text] [Related]
17. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
19. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.
Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X
J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 Dependent Endocytosis Enhances the Chemosensitivity of HER-2 Positive Breast Cancer Cells to Trastuzumab Emtansine (T-DM1).
Chung YC; Kuo JF; Wei WC; Chang KJ; Chao WT
PLoS One; 2015; 10(7):e0133072. PubMed ID: 26172389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
